These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 17340127)

  • 21. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioidergic modulation of ethanol self-administration in the ventral pallidum.
    Kemppainen H; Raivio N; Suo-Yrjo V; Kiianmaa K
    Alcohol Clin Exp Res; 2012 Feb; 36(2):286-93. PubMed ID: 21895714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
    Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
    Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    Emmerson PJ; McKinzie JH; Surface PL; Suter TM; Mitch CH; Statnick MA
    Eur J Pharmacol; 2004 Jun; 494(2-3):121-30. PubMed ID: 15212965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
    Nelson CJ; Schneider GM; Lysle DT
    Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.
    Maguire P; Tsai N; Kamal J; Cometta-Morini C; Upton C; Loew G
    Eur J Pharmacol; 1992 Mar; 213(2):219-25. PubMed ID: 1355735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy.
    McLamore S; Ullrich T; Rothman RB; Xu H; Dersch C; Coop A; Davis P; Porreca F; Jacobson AE; Rice KC
    J Med Chem; 2001 Apr; 44(9):1471-4. PubMed ID: 11311071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
    Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor.
    Remmers AE; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1999 Feb; 288(2):827-33. PubMed ID: 9918595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of structural modifications of N-CPM-normorphine derivatives on agonist and antagonist activities in isolated organs.
    Riba P; Tóth Z; Hosztafi S; Friedmann T; Fürst S
    Acta Biol Hung; 2003; 54(2):177-81. PubMed ID: 14535623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.
    Husbands SM; Neilan CL; Broadbear J; Grundt P; Breeden S; Aceto MD; Woods JH; Lewis JW; Traynor JR
    Eur J Pharmacol; 2005 Feb; 509(2-3):117-25. PubMed ID: 15733546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective interference of beta-arrestin 1 with kappa and delta but not mu opioid receptor/G protein coupling.
    Cheng ZJ; Yu QM; Wu YL; Ma L; Pei G
    J Biol Chem; 1998 Sep; 273(38):24328-33. PubMed ID: 9733719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates.
    Lewanowitsch T; Irvine RJ
    Brain Res; 2003 Feb; 964(2):302-5. PubMed ID: 12576191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.